IFG Advisory’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,506
| Closed | -$240K | – | 507 |
|
|
2021
Q3 | $240K | Buy |
2,506
+33
| +1% | +$3.16K | 0.03% | 432 |
|
|
2021
Q2 | $240K | Buy |
+2,473
| New | +$240K | 0.03% | 423 |
|
|
2020
Q4 | – | Sell |
-2,264
| Closed | -$217K | – | 454 |
|
|
2020
Q3 | $217K | Buy |
2,264
+35
| +2% | +$3.36K | 0.04% | 377 |
|
|
2020
Q2 | $271K | Sell |
2,229
-100
| -4% | -$12.2K | 0.05% | 323 |
|
|
2020
Q1 | $201K | Sell |
2,329
-2,278
| -49% | -$197K | 0.04% | 342 |
|
|
2019
Q4 | $495K | Buy |
+4,607
| New | +$495K | 0.09% | 235 |
|